Company intelligence / Profile preview

Leafio

Melbourne, Victoria, Australiamontu.com.au ↗

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Leafio is a leading Australian medicinal cannabis wholesaler and distributor, operating as the wholesale arm of the healthcare technology group Montu. Established in 2023, the company manages a sophisticated nationwide supply chain that connects over 100 global and local cannabis brands to a network of more than 4,000 pharmacies across Australia. Leafio focuses on a "pharmacy-first" approach, providing rapid delivery, clinical education, and regulatory support to healthcare professionals and pharmacists. In late 2025, the company solidified its market position through a major strategic distribution partnership with Aurora Cannabis and its subsidiary MedReleaf Australia.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculePlant-based therapy
Industry: Biotech

Partnerships

Aurora CannabisMedReleaf AustraliaSOMAÍ Pharmaceuticals

Beyond the preview

Go deeper on Leafio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leafio.